XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Mezzanine Equity and Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2023   72,533,754        
Stockholders' equity at beginning of period at Dec. 31, 2023 $ 45,893 $ 7 $ (5,445) $ 690,055 $ (24,910) $ (613,814)
Stockholders’ Deficit            
Shares issued in connection with equity incentive plans (in shares)   720,091        
Stock-based compensation expense and vesting of restricted stock units 3,839     3,839    
Preferred stock accretion 0          
Other (63)         (63)
Other comprehensive income (loss) (885)       (885)  
Net loss (33,099)         (33,099)
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2024   73,253,845        
Stockholders' equity at end of period at Jun. 30, 2024 15,685 $ 7 (5,445) 693,894 (25,795) (646,976)
Common stock, shares outstanding at beginning of period (in shares) at Mar. 31, 2024   72,643,445        
Stockholders' equity at beginning of period at Mar. 31, 2024 29,547 $ 7 (5,445) 691,889 (26,643) (630,261)
Stockholders’ Deficit            
Shares issued in connection with equity incentive plans (in shares)   610,400        
Stock-based compensation expense and vesting of restricted stock units 2,005     2,005    
Other (63)         (63)
Other comprehensive income (loss) 848       848  
Net loss (16,652)         (16,652)
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2024   73,253,845        
Stockholders' equity at end of period at Jun. 30, 2024 $ 15,685 $ 7 (5,445) 693,894 (25,795) (646,976)
Mezzanine Equity at beginning of period (in shares) at Dec. 31, 2024 28,000.00001          
Mezzanine Equity at beginning of period at Dec. 31, 2024 $ 23,861          
Mezzanine Equity            
Conversion of convertible preferred stock (in shares) (7,000)          
Conversion of convertible preferred stock $ (7,000)          
Preferred stock accretion $ 2,269          
Mezzanine Equity at end of period (in shares) at Jun. 30, 2025 21,000.00001          
Mezzanine Equity at end of period at Jun. 30, 2025 $ 19,130          
Common stock, shares outstanding at beginning of period (in shares) at Dec. 31, 2024 89,861,035 89,861,035        
Stockholders' equity at beginning of period at Dec. 31, 2024 $ (7,731) $ 9 (5,445) 718,797 (27,455) (693,637)
Stockholders’ Deficit            
Shares issued in connection with equity incentive plans (in shares)   1,020,102        
Shares issued in connection with equity incentive plans 1 $ 1        
Stock-based compensation expense and vesting of restricted stock units 2,353     2,353    
Conversion of convertible preferred stock (in shares)   3,784,688        
Conversion of convertible preferred stock 7,000     7,000    
Preferred stock accretion (2,269)     (2,269)    
Other (376)         (376)
Other comprehensive income (loss) 252       252  
Net loss $ (16,720)         (16,720)
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2025 94,665,825 94,665,825        
Stockholders' equity at end of period at Jun. 30, 2025 $ (17,490) $ 10 (5,445) 725,881 (27,203) (710,733)
Mezzanine Equity at beginning of period (in shares) at Mar. 31, 2025 21,000.00001          
Mezzanine Equity at beginning of period at Mar. 31, 2025 $ 18,374          
Mezzanine Equity            
Preferred stock accretion $ 756          
Mezzanine Equity at end of period (in shares) at Jun. 30, 2025 21,000.00001          
Mezzanine Equity at end of period at Jun. 30, 2025 $ 19,130          
Common stock, shares outstanding at beginning of period (in shares) at Mar. 31, 2025   93,934,569        
Stockholders' equity at beginning of period at Mar. 31, 2025 (11,379) $ 9 (5,445) 724,971 (28,196) (702,718)
Stockholders’ Deficit            
Shares issued in connection with equity incentive plans (in shares)   731,256        
Shares issued in connection with equity incentive plans 1 $ 1        
Stock-based compensation expense and vesting of restricted stock units 1,666     1,666    
Preferred stock accretion (756)     (756)    
Other (336)         (336)
Other comprehensive income (loss) 993       993  
Net loss $ (7,679)         (7,679)
Common stock, shares outstanding at end of period (in shares) at Jun. 30, 2025 94,665,825 94,665,825        
Stockholders' equity at end of period at Jun. 30, 2025 $ (17,490) $ 10 $ (5,445) $ 725,881 $ (27,203) $ (710,733)